Technavio estimates global bipolar disorder therapeutics market to reach over $7.5 billion by 2019
Segmentation of the bipolar disorder therapeutics market by drug class (mood stabilizers, anticonvulsants, atypical antipsychotics, antidepressant drugs, and anti-anxiety drugs), by mechanism of action (selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta blockers, and others), and by geography (the Americas, APAC, and EMEA). Top vendors include Allergan, AstraZeneca,…